This trial looks at a dietary supplement to see if it safely reduces hot flashes in menopausal women.
- Hot Flashes
- Postmenopausal Disorders
1 Primary · 4 Secondary · Reporting Duration: 12 weeks
2 Treatment Groups
Test Product: JDS-HF3.0 Capsules
1 of 2
1 of 2
64 Total Participants · 2 Treatment Groups
Primary Treatment: Test Product: JDS-HF3.0 Capsules · Has Placebo Group · N/A
Who is running the clinical trial?
Age 40 - 65 · Female Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this study open to adolescents below the age of twenty?
"Participants must be between 40 and 65 years of age to meet the qualifications for this trial." - Anonymous Online Contributor
Are there any requirements that preclude me from entering this trial?
"Recruitment for this trial is targeting 64 individuals between the ages of 40 and 65, who are suffering from hot flashes." - Anonymous Online Contributor
Is there still availability for individuals to join this clinical experiment?
"Indeed, clinicaltrials.gov displays that this medical trial is still open for recruitment and was first posted on May 1st 2023 with its latest update occurring on April 12th, 2023. The study is in need of 64 participants from 2 distinct sites." - Anonymous Online Contributor
To what extent is the enrollment for this trial open?
"Affirmative. The clinicaltrials.gov portal confirms that this research project, which was initially announced on May 1st 2023, is currently recruiting participants. Specifically, the team needs 64 individuals from 2 distinct medical institutions." - Anonymous Online Contributor